Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.27 USD | +17.59% |
|
+34.18% | +2.42% |
Jul. 11 | Sector Update: Health Care Stocks Advance Premarket Thursday | MT |
Jul. 11 | Akebia Regains Full Rights to Sell Vafseo Tablets in US After Ending Licensing Deal With CSL Vifor | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.42% | 226M | |
+20.95% | 127B | |
+23.00% | 116B | |
+25.15% | 27.69B | |
-19.75% | 19.62B | |
-16.57% | 16.26B | |
-16.56% | 15.49B | |
+11.19% | 14.81B | |
-46.65% | 14.39B | |
+57.74% | 14.11B |
- Stock Market
- Equities
- AKBA Stock
- News Akebia Therapeutics, Inc.
- Transcript : Akebia Therapeutics, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-13-2021 11